J&J Gets FDA Approval of New Chemo-Free Lung Cancer Treatment
Johnson & Johnson announced Tuesday that it has received FDA approval for a pair of drugs to be used as a chemotherapy-free treatment for certain types of lung cancer. The company also announced the $1.7 billion acquisition of heart treatment company V-Wave.
( 22
min )